Key COVID-19 Studies Influencing My Practice Following IDWeek 2021*

Join Arthur Kim, MD, or Renslow Sherer, MD, in a live, interactive, CME/CE/CPE-certified webinar providing a rapid update and answering your questions on key COVID-19 treatment and preventions studies from the IDWeek 2021 scientific meeting.

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Agenda

Program Overview (5 mins)

Key COVID-19 Studies Influencing My Practice Following IDWeek 2021 (30 mins)

  • Transmission and vaccines
  • Monoclonal antibodies for prevention and treatment
  • Direct-acting antivirals
  • Long-term COVID-19 outcomes

Question and Answer Session (10 mins)

Events

Date / Time
Event Details

Faculty

Faculty
Arthur Kim, MD

Associate Professor
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Boston, Massachusetts

Faculty
Renslow Sherer, MD

Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois

Goal Statement

The goal of this activity is to improve learners’ competence in translating the most clinically significant data from IDWeek 2021 into practical management strategies for individuals at risk of or diagnosed with COVID-19.

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients at risk of or diagnosed with COVID-19.

Learning Objectives

  • Integrate new data from studies of vaccines and monoclonal antibodies into prevention strategies for SARS-CoV-2 infection
  • Apply safety and efficacy data from recent clinical studies of evolving therapeutics for outpatients and hospitalized patients with COVID-19

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.

Continuing Pharmacy Education

CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-196-L01-P

Type of Activity: Knowledge

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.